Replies to post #369704 on NorthWest Biotherapeutics Inc (NWBO)

[10baggerz]

You’re probably right, but I’d caution saying things like “there is no way.” We ran to $2.50 on sleuthing by ALTInsider that the UK had updated their SAP.
I see a technical pattern in the chart nearly identical to the run up from .26 to 2.50.
Also if NWBO simply updated clinicaltrials.gov IMO we’d be over 2.
If they announce an ASCO abstract, publication acceptance in a top tier journal or any sort of accelerated approval status in the US, we could easily get over 2.50 before TLD.
Again you’re probably right, but stocks, particularly OTC stocks, do counterintuitive things. I don’t think anyone at $2.50 would’ve said we’d be at .94 within a week.
Nothing has changed in my option except for a delay.